Clinical Trial Update: SLC2A1 Variants and Diabetic Nephropathy

View source ↗

Summary

A completed clinical trial from University of Sao Paulo General Hospital studied SLC2A1 gene variants in relation to diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Diabetic Nephropathy. | Status: COMPLETED